385 related articles for article (PubMed ID: 26350342)
1. Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.
Heissig B; Dhahri D; Eiamboonsert S; Salama Y; Shimazu H; Munakata S; Hattori K
Cell Mol Life Sci; 2015 Dec; 72(24):4759-70. PubMed ID: 26350342
[TBL] [Abstract][Full Text] [Related]
2. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots.
Neuss S; Schneider RK; Tietze L; Knüchel R; Jahnen-Dechent W
Cells Tissues Organs; 2010; 191(1):36-46. PubMed ID: 19390164
[TBL] [Abstract][Full Text] [Related]
3. [The urokinase-type plasminogen activator system and its role in tumor progression].
Kugaevskaya EV; Gureeva TA; Timoshenko OS; Solovyeva NI
Biomed Khim; 2018 Nov; 64(6):472-486. PubMed ID: 30632975
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis: the key to new pathogenetic mechanisms.
Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
[TBL] [Abstract][Full Text] [Related]
5. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
6. Urokinase plasminogen receptor and the fibrinolytic complex play a role in nerve repair after nerve crush in mice, and in human neuropathies.
Rivellini C; Dina G; Porrello E; Cerri F; Scarlato M; Domi T; Ungaro D; Del Carro U; Bolino A; Quattrini A; Comi G; Previtali SC
PLoS One; 2012; 7(2):e32059. PubMed ID: 22363796
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract.
Sandra D; Radha M; Harishkumar M; Yuichi N; Sayuri O; Masugi M
Phytomedicine; 2010 Jan; 17(1):42-6. PubMed ID: 19640694
[TBL] [Abstract][Full Text] [Related]
8. Confluence switch signaling regulates ECM composition and the plasmin proteolytic cascade in keratinocytes.
Botta A; Delteil F; Mettouchi A; Vieira A; Estrach S; Négroni L; Stefani C; Lemichez E; Meneguzzi G; Gagnoux-Palacios L
J Cell Sci; 2012 Sep; 125(Pt 18):4241-52. PubMed ID: 22641690
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.
Czekay RP; Loskutoff DJ
J Cell Physiol; 2009 Sep; 220(3):655-63. PubMed ID: 19472211
[TBL] [Abstract][Full Text] [Related]
10. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
[TBL] [Abstract][Full Text] [Related]
12. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
Choong PF; Nadesapillai AP
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S46-58. PubMed ID: 14600592
[TBL] [Abstract][Full Text] [Related]
13. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
Idell S
Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk.
Beloglazova I; Stepanova V; Zubkova E; Dergilev K; Koptelova N; Tyurin-Kuzmin PA; Dyikanov D; Plekhanova O; Cines DB; Mazar AP; Parfyonova Y
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119157. PubMed ID: 34619163
[TBL] [Abstract][Full Text] [Related]
15. Cancer therapy targeting the fibrinolytic system.
Heissig B; Eiamboonsert S; Salama Y; Shimazu H; Dhahri D; Munakata S; Tashiro Y; Hattori K
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):172-179. PubMed ID: 26588878
[TBL] [Abstract][Full Text] [Related]
16. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
Costantini V; Sidoni A; Deveglia R; Cazzato OA; Bellezza G; Ferri I; Bucciarelli E; Nenci GG
Cancer; 1996 Mar; 77(6):1079-88. PubMed ID: 8635127
[TBL] [Abstract][Full Text] [Related]
17. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.
Bonavaud S; Charrière-Bertrand C; Rey C; Leibovitch MP; Pedersen N; Frisdal E; Planus E; Blasi F; Gherardi R; Barlovatz-Meimon G
J Cell Sci; 1997 May; 110 ( Pt 9)():1083-9. PubMed ID: 9175704
[TBL] [Abstract][Full Text] [Related]
18. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
19. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
Baker EA; Bergin FG; Leaper DJ
Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]